3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Recurrence
1
Lymphoma, Large B-Cell, Diffuse
1
Dendritic Cell Sarcoma, Interdigitating
1
Interventions
Specimen Handling
271
Magnetic Resonance Spectroscopy
222
pembrolizumab
216
Carboplatin
175
Biopsy
166
Cisplatin
155
Nivolumab
150
Cyclophosphamide
135
Paclitaxel
120
Radiotherapy
117
Gemcitabine
111
Bevacizumab
93
durvalumab
85
Dexamethasone
83
Rituximab
76
Oxaliplatin
71
atezolizumab
70
Doxorubicin
67
Capecitabine
67
Fluorouracil
66
venetoclax
65
Etoposide
64
Docetaxel
64
Radiosurgery
58
Radiation
57
Cytarabine
57
Prednisone
56
Pemetrexed
55
Ipilimumab
55
Lenalidomide
54
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Weights and Measures
×
90 days
×
Clear all
NCT04113226
2026-06-12
Relyage
Centre Hospitalier Universitaire, Amiens
Phase 2
Completed
1 enrolled